Literature DB >> 9626878

Three-dimensional low dose gadolinium-enhanced peripheral MR venography.

W Li1, V David, R Kaplan, R R Edelman.   

Abstract

Our initial experience with low dose contrast-enhanced (LCE) peripheral MR venography (MRV) is presented. Five subjects were studied using three-dimensional (3D) fast imaging with a steady-state precession (FISP) sequence. A dose of 60 ml of gadopentetate dimeglumine diluted 1:20 was used. A tourniquet was applied during lower extremity MR venography. The venous anatomy was well depicted with the 3D LCE technique in all subjects. Compared to the two-dimensional (2D) time-of-flight (TOF) technique, acquisition time of 3D LCE MRV was much shorter, images looked sharper, and more veins could be seen. It is not affected by in-plane saturation and can be performed repeatedly because of the low dose of contrast. This technique holds promise for the detection of venous thrombosis and other disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626878     DOI: 10.1002/jmri.1880080317

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Contrast enhanced body magnetic resonance angiography.

Authors:  A E Stillman
Journal:  Int J Card Imaging       Date:  1999-04

Review 2.  Vascular anomalies: what a radiologist needs to know.

Authors:  Josée Dubois; Marianne Alison
Journal:  Pediatr Radiol       Date:  2010-04-30

3.  Magnetic resonance venography and genetics of a female patient with pelvic venous thrombosis.

Authors:  Thomas G Perkins; Rahul K Mishra; Yasmin Siddiqui; Eric H Hanson; Robb K Rowley; Erica R Ramos; William W Orrison
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 4.  Current techniques for assessment of upper extremity vasculature prior to hemodialysis vascular access creation.

Authors:  R N Planken; J H M Tordoir; L E M Duijm; M W de Haan; T Leiner
Journal:  Eur Radiol       Date:  2007-05-08       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.